Taken together, these findings demonstrate that PD-1 deficiency or anti–PD-1 therapy in mice with liver injury is associated with improved KC bacterial clearance, reduced tissue bacterial burden, and protection from sepsis after infection. This evidence concerns the gene CALCA and Sepsis.